What's Next in Health Data with ConcertAI

As the role of real-world data (RWD) in life sciences shifts from supportive to strategic, organizations are rethinking how data platforms, partnerships, and AI-powered tools can accelerate the path from insight to impact.

In part two of Datavant’s What’s Next in Health Data series, Arnaub Chatterjee, President & GM of Life Sciences at Datavant, sits down with Jeff Elton, Vice Chairman and former founding CEO of ConcertAI, to explore the evolving utility of health data and and its potential to reshape oncology, translational research, and enterprise innovation.

This 30-minute fireside chat is designed for senior leaders and strategists, offering a forward-looking view into the infrastructure, governance, and insights required to compete in a data-first era.